Publication Author: Sullivan_Sean

• Global epidemiology of hepatitis B virus.

  Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004 Nov-Dec;38(10 Suppl 3):S158-68. Review.

  rakerr2

  November 1, 2004

• Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.

  Taylor RS, Drummond MF, Salkeld G, Sullivan SD. Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle. BMJ. 2004 Oct 23;329(7472):972-5. Review.

  rakerr2

  October 23, 2004

• Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease.

  Lee TA, Weiss KB, Sullivan SD. Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease. Am J Med. 2004 Oct 15;117(8):618; author reply 618-9.

  rakerr2

  October 15, 2004

• Quantifying losses to the donated blood supply due to donor deferral and miscollection.

  Custer B, Johnson ES, Sullivan SD, Hazlet TK, Ramsey SD, Hirschler NV, Murphy EL, Busch MP. Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion. 2004 Oct;44(10):1417-26.

  rakerr2

  October 1, 2004

• Country-specific cost-effectiveness of early intervention with budesonide in mild asthma.

  Buxton MJ, Sullivan SD, Andersson LF, Lamm CJ, Liljas B, Busse WW, Pedersen S, Weiss KB. Country-specific cost-effectiveness of early intervention with budesonide in mild asthma. Eur Respir J. 2004 Oct;24(4):568-74.

  rakerr2

  October 1, 2004

• Comments on Clinical and economic comparison of epoetin alfa and darbepoetin alfa.

  Sullivan SD. Comments on Clinical and economic comparison of epoetin alfa and darbepoetin alfa. Curr Med Res Opin. 2004 Sep;20(9):1461; author reply 1462-3.

  rakerr2

  September 1, 2004

• A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study.

  Lozano P, Finkelstein JA, Carey VJ, Wagner EH, Inui TS, Fuhlbrigge AL, Soumerai SB, Sullivan SD, Weiss ST, Weiss KB. A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of th

  rakerr2

  September 1, 2004

• Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and ribavirin in patients with chronic hepatitis C.

  Sullivan SD, Jensen DM, Bernstein DE, Hassanein TI, Foster GR, Lee SS, Cheinquer H, Craxi A, Cooksley G, Klaskala W, Pettit K, Patel KK, Green J. Cost-effectiveness of combination peginterferon alpha-2a and ribavirin compared with interferon alpha-2b and

  rakerr2

  August 1, 2004

• Consensus guidelines for specialty pharmaceuticals: a best-practice approach for cost-effective management.

  Sullivan SD. Consensus guidelines for specialty pharmaceuticals: a best-practice approach for cost-effective management. Am J Manag Care. 2004 Aug;10(8 Suppl):S242-4; discussion 245-51. Review.

  rakerr2

  August 1, 2004

• Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials.

  Niederman MS, Chang JR, Stewart J, Asche CV, Lavin B, Nusrat R, Sullivan SD. Hospitalization rates among patients with community-acquired pneumonia treated with telithromycin vs clarithromycin: results from two randomized, double-blind, clinical trials. C

  rakerr2

  July 1, 2004